-
In section: UMass Chan News
In subsection: News Archives
The next Neuroscience of Disease Forum will take place on Monday, Oct. 15, from 3:30 p.m. to 6 p.m., in the Faculty Conference Room at UMass Medical School. It will feature talks by Shlomit Schaal, MD, PhD, and Claudio Punzo, PhD, on retinitis pigmentosa.
Last modified: Oct 05, 2018
-
In section: UMass Chan News
In subsection: News Archives
First-year medical student Tedi Begaj is the recipient of a Howard Hughes Medical Institute Summer Medical Fellows Program award, which he will use to explore the possibility of utilizing gene therapy for treatment of retinitis pigmentosa.
Last modified: Dec 12, 2013
-
In section: UMass Chan News
In subsection: News Archives
affected by choroideremia, retinitis pigmentosa is a similar but more common disease of the rods and cones that affects many more. “The incidence of choroideremia is about one in 50,000, whereas retinitis pigmentosa is a relatively more frequent disease that affects one in 3,000 to 4,000,” said Hemant Khanna, PhD, assistant professor of ophthalmology, who was also not involved in the Oxford study. “This treatment does hold promise for such diseases as retinitis pigmentosa where we can now target photoreceptors
Last modified: Feb 10, 2014
-
In section: UMass Chan News
In subsection: News Archives
scientist at UMass Medical School. If you know of a researcher you’d like to see profiled, send an email to UMassChanCommunications@umassmed.edu. Name: Hemant Khanna, PhD, assistant professor of ophthalmology Project names and amounts: X-linked Retinitis Pigmentosa, National Eye Institute; three years, $864,486 Molecular Mechanism of pathogenesis and possible treatment strategies for X-linked retinal degenerative diseases, Foundation Fighting Blindness; five years, $225,000 Midwest Eye Banks and Transplantation
Last modified: Dec 20, 2013
-
In section: UMass Chan News
In subsection: News Archives
Medical Research Fellowship from the Howard Hughes Medical Institute. He will conduct research to develop and deliver adeno-associated viral gene therapy in retinitis pigmentosa.
Tedi Begaj, a third year student in the School of Medicine, is conducting research to develop and deliver adeno-associated viral gene therapy in retinitis pigmentosa. Tedi Begaj, a third year student in the School of Medicine, has been awarded a Medical Research Fellowship from the Howard Hughes Medical Institute. He will
Last modified: Apr 27, 2015
-
In section: UMass Chan News
In subsection: News Archives
of Chromosome Conformation Capture Data and Their Application to Study Long-Range Gene Regulation Job Dekker, PhD, mentor Recognition of Class Speaker Aditya Venkatesh Activation of mTORC1 Improves Cone Cell Metabolism and Extends Vision in Retinitis Pigmentosa Mice Claudio Punzo, PhD, mentor Recognition of Travel Awards GSBS Student Travel Awards Navonil Banergee Michael Francis, PhD, mentor Natasha Qaisar Jennifer Wang, PhD, mentor Riccio GSBS Student Travel Awards Srinjoy Chakraborti Sanjay Ram
Last modified: Jun 03, 2016
-
In section: UMass Chan News
In subsection: News Archives
microbiology & physiological systems, is studying gene therapy for the prevention of retinal degeneration. Millions of Americans are visually impaired due to retinal degenerative diseases such as macular degeneration, diabetic retinopathy and retinitis pigmentosa. Volkert’s proposed gene therapy reduces the oxidative stress that causes cell death in most retinal degenerative diseases. “We are targeting a common feature of many different retinal degenerative diseases with the potential of saving the
Last modified: Dec 12, 2019
-
In section: UMass Chan News
In subsection: News Archives
edge biology to produce these potentially breakthrough medicines with high quality and efficiency." At the Horae Gene Therapy Center, ongoing research is developing therapies for rare diseases such as Canavan, Tay-Sachs and Sandhoff diseases; retinitis pigmentosa; alpha-antitrypsin deficiency; cystic fibrosis; and Lou Gehrig’s and Huntington’s diseases.
MMMM dd, yyyy
310,311,316,303
floatLeft
Last modified: Apr 08, 2021
-
In section: UMass Chan News
In subsection: News Archives
in autosomal recessive Stargardt disease and USH2A-related inherited retinal diseases (IRDs). These are a group of large orphan IRDs, the latter of which includes Usher syndrome type 2A and USH2A-associated nonsyndromic autosomal recessive retinitis pigmentosa.
MMMM dd, yyyy
311,316
floatRight
Last modified: Sep 11, 2019
-
In section: UMass Chan News
In subsection: News Archives
UMass Chan, he got involved in ophthalmology research—learning how the eye connects to the brain and how the retina works—and quickly fell in love with the field. He spent time during his first year working in a lab focused on gene therapy and retinitis pigmentosa, a disorder that causes childhood blindness, researching molecular pathways that lead to illness. Currently, he works in a lab focused on ocular gene therapy and macular degeneration with Haijiang Lin, MD, PhD, associate professor of ophthalmology
Last modified: Jan 19, 2022